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RNA interference discovery has opened up new fields of study, including the understanding of 
dysregulation occurring in pathogenesis, especially in cancerogenesis. Through this mechanism, the 
controlled specific down-regulation improves the identification of gene function involved in a 
biological mechanism and their contribution in an altered phenotype
1
. In this way, high-throughput 
screening (HTS) of RNAi has emerged as a potent tool in order to study a large number of gene 
functions for the identification of new biomarkers and/or therapeutic targets. However, HTS requires 
for that purpose generic carriers with highly efficient transfection. Recently, progresses have been 
made regarding the design of non-viral vectors (lipids, peptides, polymers) as delivery agents
2
. The 
efficiency and specificity of gene-based expression of siRNA have been improved, while at the same 
time reducing toxicity. Among these carriers, lipid-based agents, already used as commercial reagents 
for in vitro transfection, are considered as a promising approach for siRNA delivery. 
Here, we have developed novel nanostructured lipid carriers through a design of experiment 
approach which promote high transfection efficiency in several human cell lines. These lipid 
nanoparticles present an outstanding colloidal stability, whereas their cationic shell promotes ready-
to-use features for fast and simple complexation with nucleic acids by electrostatic bonds 
establishment, without inducing cytotoxicity. As evidenced by gel retardation assay, complexation is 
stable over time, even in cell culture media, enabling thus stable transfection efficiency for all samples 
in a protocol of large-scale screening.  Compared to the commercially available lipoplexes, these lipid 
nanoemulsions offer the possibility to combine several functions into a unique carrier, such as 
fluorescent particle tracking through the encapsulation of lipophilic dyes and/or the co-delivery of 
other drugs
3
. Thereby, the distribution monitoring into cells with nanocarriers entrapping lipophilic 
cyanine derivatives demonstrates an improved internalization of nucleic acids. Furthermore, 
preliminary experiments performed on primary cells in culture demonstrated also an improved 
transfection compared to commercially available lipoplexes, opening thus the way for RNAi screening 
in that cells recognised as hard to transfect 
Besides, ligand moieties can be grafted onto the particle surface in order to selectively target a 
specific subset of cells. Such cationic lipid nanodroplets open new avenues in the development of high 
throughput RNAi screening as well as their translation to clinics. 
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A/ Structure of lipid nanoemulsions, namely Lipidots®, after incorporation of cationic compounds in 
order to complex negatively charged siRNA. B/ Gel retardation assay showing efficient complexation 
of siRNA on lipid nanoparticles. C/ Dot plots obtained by FACS displaying the fast internalisation of 
cationic lipid nanoparticles doped with DiD (APC-A) complexed with siRNA labelled with Alexa-488 
(FITC-A) overtime. D) Epifluorescence imaging of prostatic cells overexpressing GFP protein (T0) after 
internalization of cationic Lipidot/siRNA complex (7h) and after specific down-regulation of GFP 
protein by siRNA (26h). 
 




























T0 7h 26h 
